Management of Hepatocellular Cancer in the time of SARS‐CoV‐2

by Sharma, Rohini, Pinato, David J.
Published in Liver Int (2020)

Concomitant medications and immune checkpoint inhibitor therapy for cancer: causation or association?

by Hussain, Nadiya, Naeem, Muntaha, Pinato, David J.
Published in Hum Vaccin Immunother (2020)

Back from the brink: EGFR inhibition in gastroesophageal cancer

by Openshaw, Mark R., Pinato, David J., Valeri, Nicola
Published in Clin Cancer Res (2021)

Recent advances in HIV-associated Kaposi sarcoma

by Dalla Pria, Alessia, Pinato, David J., Bracchi, Margherita, Bower, Mark
Published in F1000Res (2019)

Challenges and Opportunities in the Clinical Development of STING Agonists for Cancer Immunotherapy

by Motedayen Aval, Leila, Pease, James E., Sharma, Rohini, Pinato, David J.
Published in J Clin Med (2020)

Evaluating the impact of COVID‐19 on supportive care needs, psychological distress and quality of life in UK cancer survivors and their support network

by Hulbert‐Williams, Nicholas J., Leslie, Monica, Hulbert‐Williams, Lee, Smith, Eilidh, Howells, Lesley, Pinato, David J.
Published in Eur J Cancer Care (Engl) (2021)

Clinical, Ethical and Financial Implications of Incidental Imaging Findings: Experience from a Phase I Trial in Healthy Elderly Volunteers

by Pinato, David J., Stavraka, Chara, Tanner, Mark, Esson, Audrey, Jacobson, Eric W., Wilkins, Martin R., Libri, Vincenzo
Published 2012

Programmed death ligand 1 (PD-L1) expression influences the immune-tolerogenic microenvironment in antiretroviral therapy-refractory Kaposi's sarcoma: A pilot study

by Mletzko, Salvinia, Pinato, David J., Robey, Rebecca C., Dalla Pria, Alessia, Benson, Peter, Imami, Nesrina, Bower, Mark
Published in Oncoimmunology (2017)

Programmed cell death ligands expression in phaeochromocytomas and paragangliomas: Relationship with the hypoxic response, immune evasion and malignant behavior

by Pinato, David J., Black, James R., Trousil, Sebastian, Dina, Roberto E., Trivedi, Pritesh, Mauri, Francesco A., Sharma, Rohini
Published in Oncoimmunology (2017)

Blood Epstein–Barr virus DNA does not predict outcome in advanced HIV-associated Hodgkin lymphoma

by Ul-Haq, Ikram, Dalla Pria, Alessia, Suardi, Elisa, Pinato, David J., Froeling, Fieke, Forni, John, Randell, Paul, Bower, Mark
Published in Med Oncol (2018)

Antibiotic therapy and outcome from immune-checkpoint inhibitors

by Pinato, David J., Gramenitskaya, Daria, Altmann, Daniel M., Boyton, Rosemary J., Mullish, Benjamin H., Marchesi, Julian R., Bower, Mark
Published in J Immunother Cancer (2019)

Immunotoxicity from checkpoint inhibitor therapy: clinical features and underlying mechanisms

by Fessas, Petros, Possamai, Lucia A., Clark, James, Daniels, Ella, Gudd, Cathrin, Mullish, Benjamin H., Alexander, James L., Pinato, David J.
Published in Immunology (2019)

Intra-tumoral heterogeneity in the expression of programmed-death (PD) ligands in isogeneic primary and metastatic lung cancer: Implications for immunotherapy

by Pinato, David J., Shiner, Robert J., White, Solomon D. T., Black, James R. M., Trivedi, Pritesh, Stebbing, Justin, Sharma, Rohini, Mauri, Francesco A.
Published in Oncoimmunology (2016)

Integrated analysis of multiple receptor tyrosine kinases identifies Axl as a therapeutic target and mediator of resistance to sorafenib in hepatocellular carcinoma

by Pinato, David J., Brown, Matthew W., Trousil, Sebastian, Aboagye, Eric O., Beaumont, Jamie, Zhang, Hua, Coley, Helen M., Mauri, Francesco A., Sharma, Rohini
Published in Br J Cancer (2019)

Prognostic sub-classification of intermediate-stage hepatocellular carcinoma: a multicenter cohort study with propensity score analysis

by Ramaswami, Ramya, Pinato, David J., Kubota, Keiichi, Ishizuka, Mitsuru, Arizumi, Tadaaki, Kudo, Masatoshi, Jang, Jeong Won, Kim, Young Woon, Pirisi, Mario, Allara, Elias, Sharma, Rohini
Published in Med Oncol (2016)

Immune-based therapies for hepatocellular carcinoma

by Pinato, David J., Guerra, Nadia, Fessas, Petros, Murphy, Ravindhi, Mineo, Takashi, Mauri, Francesco A., Mukherjee, Sujit K., Thursz, Mark, Wong, Ching Ngar, Sharma, Rohini, Rimassa, Lorenza
Published in Oncogene (2020)

Preliminary qualification of a novel, hypoxic-based radiologic signature for trans-arterial chemoembolization in hepatocellular carcinoma

by Pinato, David J., Pai, Madhava, Reccia, Isabella, Patel, Markand, Giakoustidis, Alexandros, Karamanakos, Georgios, Rushd, Azelea, Jamshaid, Shiraz, Oldani, Alberto, Grossi, Glenda, Pirisi, Mario, Tait, Paul, Sharma, Rohini
Published in BMC Cancer (2018)

An Inflammation Based Score Can Optimize the Selection of Patients with Advanced Cancer Considered for Early Phase Clinical Trials

by Pinato, David J., Stavraka, Chara, Flynn, Michael J., Forster, Martin D., O'Cathail, Séan M., Seckl, Michael J., Kristeleit, Rebecca S., Olmos, David, Turnbull, Samantha J., Blagden, Sarah P.
Published 2014

Combined sequential use of HAP and ART scores to predict survival outcome and treatment failure following chemoembolization in hepatocellular carcinoma: a multi-center comparative...

by Pinato, David J., Arizumi, Tadaaki, Jang, Jeong Won, Allara, Elias, Suppiah, Puvan I., Smirne, Carlo, Tait, Paul, Pai, Madhava, Grossi, Glenda, Kim, Young Woon, Pirisi, Mario, Kudo, Masatoshi, Sharma, Rohini
Published in Oncotarget (2016)

Integration of the cancer-related inflammatory response as a stratifying biomarker of survival in hepatocellular carcinoma treated with sorafenib

by Howell, Jessica A., Pinato, David J., Ramaswami, Ramya, Arizumi, Tadaaki, Ferrari, Carlotta, Gibbin, Antonello, Burlone, Michela E., Guaschino, Giulia, Toniutto, Pierluigi, Black, James, Sellers, Laura, Kudo, Masatoshi, Pirisi, Mario, Sharma, Rohini
Published in Oncotarget (2017)